COHANCE — Cohance Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for Cohance Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IAS	IAS	IAS	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,279	4,859	8,234	3,063	3,278
Net Total Accounts Receivable
Net Total Receivables	2,930	1,849	2,008	7,746	6,891
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11,279	10,110	12,632	17,582	17,963
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,620	7,662	7,868	20,964	21,633
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	18,296	19,657	22,541	54,810	57,296
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,103	1,588	1,069	7,054	6,459
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,024	2,306	2,034	18,321	18,184
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	15,272	17,352	20,507	36,488	39,113
Total Liabilities & Shareholders' Equity	18,296	19,657	22,541	54,810	57,296
Total Common Shares Outstanding